Spine biologics are a type of medical technology that use natural substances, such as growth factors and stem cells, to stimulate healing and regeneration of the spine. In this blog, we'll explore the basics of spine biologics and how they are used in spine surgery.
What are Spine Biologics?
Spine biologics are natural substances that are used to stimulate healing and regeneration of the spine. These substances can be derived from a patient's own body, such as stem cells, or from external sources, such as growth factors and proteins.
Get More Information: https://www.coherentmarketinsights.com/market-insight/spine-biologics-market-4495
Types of Spine Biologics
There are several types of spine biologics, including:
Bone morphogenetic proteins (BMPs) - BMPs are proteins that stimulate bone growth and regeneration. They are used in spinal fusion surgery to help fuse the vertebrae together.
Platelet-rich plasma (PRP) - PRP is a concentration of platelets and growth factors derived from a patient's own blood. It is used to promote healing and regeneration of injured tissues in the spine.
Mesenchymal stem cells - Mesenchymal stem cells are cells that can differentiate into a variety of cell types, including bone, cartilage, and muscle. They are used in spinal surgery to promote bone growth and repair.
Demineralized bone matrix (DBM) - DBM is a material that is derived from human bone tissue. It is used in spinal fusion surgery to promote bone growth and regeneration.
Benefits of Spine Biologics
Spine biologics offer several benefits over traditional spinal surgery methods, including:
Improved healing - Spine biologics can help stimulate the body's natural healing and regeneration processes, which can lead to improved healing and recovery times.
Reduced risk of complications - Spine biologics are made from natural substances, which can reduce the risk of complications and adverse reactions compared to synthetic materials.
Reduced need for additional surgeries - Spine biologics can help improve the success rate of spinal surgeries, which can reduce the need for additional surgeries in the future.
Reduced need for pain medication - Spine biologics can help reduce the amount of pain medication needed during and after spinal surgery, which can reduce the risk of opioid addiction and other side effects.
Conclusion:
Spine biologics offer a promising new approach to spinal surgery. They offer several benefits over traditional spinal surgery methods, including improved healing, reduced risk of complications, and reduced need for additional surgeries and pain medication. If you are considering spinal surgery, talk to your healthcare provider about whether spine biologics may be a viable option for you.
Biologics have been an increasingly important component to be used in spinal fusion surgery, due to the growing awareness about their potential impact, usage of bone graft substitutes, and the rising geriatric population.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=17444 Spine biologics are used in the treatment of spine trauma, tumors, and degenerative diseases in order to achieve arthrodesis in case of deformity or instability.
The favored usage of biologics among surgeons, the minimal pain and invasiveness they cause, and the rise in obesity as well as geriatric population are drivers of the global spine biologics market.
Based on type of surgery, the divisions are anterior cervical discectomy and fusion (ACDF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and transforaminal lumbar interbody fusion (TLIF).
RhBMP-2 approved by FDA in 2002 and marketed as infuse by Medtronic Sofamor Danek, Inc. is used for insertion within a titanium tapered cage in anterior lumbar interbody fusion surgery.
North America holds a major share in the market, followed by Europe, due to developed technologies and hospitals, rise in the citizens’ per capita income, and improved medical literacy.
The Spinal Surgery Devices And Equipment Global Market Report 2021-30 by The Business Research Company describes and explains the global spinal surgery devices and equipment market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The report evaluates the market across each region and for the major economies within each region.The Spinal Surgery Devices And Equipment Global Market Report 2021 covers spinal surgery devices and equipment market drivers, spinal surgery devices and equipment market trends, spinal surgery devices and equipment market segments, spinal surgery devices and equipment market growth rate, spinal surgery devices and equipment market major players, and spinal surgery devices and equipment market size.View Complete Report:https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report The spinal surgery devices and equipment market report provides an in-depth analysis of the impact of COVID-19 on the global spinal surgery devices and equipment industry, along with revised market numbers due to the effects of the coronavirus and the expected spinal surgery devices and equipment market growth numbers 2021-2030.Spinal Surgery Devices And Equipment Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now:https://www.thebusinessresearchcompany.com/sample.aspx?id=2402=smpThe global spinal surgery devices and equipment market is expected to grow from $7.57 billion in 2020 to $8.26 billion in 2021 at a compound annual growth rate (CAGR) of 9.1%.
The market is expected to reach $9.7 billion in 2025 at a CAGR of 4.1%.The report covers the spinal surgery device and equipment market segments- 1) By Product Type: Spine Biologics, Surgical Spinal Decompression, Vertebral Compression Fracture Treatment Products, Non-Fusion, Fusion.2) By Application: Hospital, Ambulatory Service Centers, Orthopedic Centers.3) By Type Of Surgery: Open Surgeries, Minimally Invasive Surgeries.About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.
Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
According to the new market research report the Spinal Implants Devices Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 This market is primarily driven by the launch of advanced bone grafting products, the advancements in spine surgery technologies, increasing incidence of spinal disorders and the increasing adoption of minimally invasive spine surgeries.
The major players operating in the Spinal Surgery Devices Market are Medtronic (Ireland), DePuy Synthes (US), Orthofix International N.V. (US), Abbott Laboratories (US), NuVasive, Inc. (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Zimmer Biomet Holdings, Inc. (US), Globus Medical, Inc. (US), RTI Surgical, Inc. (US), Boston Scientific (US), SeaSpine Holdings Corporation (US), ulrich GmbH & Co. KG (Germany), Spineart (Switzerland), Kuros Biosciences AG (Switzerland), Bioventus, LLC (US), Colfax Corporation (US), Meditech Spine, LLC (US), and Implanet (France).
Based on product, the market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and spine bone stimulators.
The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the market in 2019.
The large share of this segment can be attributed to the increasing incidence of lumbar degenerative disc disease and the growing number of product launches.
